View the full CURE® Educated Patient® Summit on Prostate Cancer here!
Watch the full CURE® Educated Patient® Summit on Prostate Cancer for an insightful discussion with multiple experts from the prostate cancer field. Topics covered from this summit include new treatment methods, dealing with side effects of treatment and much more!
Novel Drug Granted FDA Fast Track in Rare Prostate Cancer Subset
February 13th 2024The Food and Drug Administration has granted a Fast Track designation to the novel immune activator drug BXCL701 in combination with a checkpoint inhibitor for patients with metastatic small cell neuroendocrine prostate cancer (SCNC).
Read More